Pharmaceutical Products Manufacturing in Mexico - Industry Market Research Report

Healthy forecast: Increasing medication accessibility in Mexico is expected to drive revenue growth

Pharmaceutical Products Manufacturing in Mexico
Over the five years to 2019, revenue for the Pharmaceutical Products Manufacturing industry in Mexico has grown marginally. The industry comprises establishments that manufacture pharmaceutical preparations and companies that produce raw materials used in the pharmaceutical product manufacturing process. Disposable medical material manufacturers are not included in this industry. During the period, the industry has benefited from an aging population, a decline in mortality, growing consumer spending and increased accessibility to medications. Over the five years to 2024, industry revenue is anticipated to continue growing at a marginal pace. A projected deceleration in inflation will put slight upward pressure on revenue growth in real terms. In addition, growing health spending in the United States and an increase in accessibility to medications in Mexico are expected to drive revenue growth over the next five years. This industry comprises establishments primarily engaged in manufacturing raw materials for the pharmaceutical industry and pharmaceutical preparations. This industry does not include establishments that mainly manufacture ethanol and disposable medical material. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.